AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock

USD 7.78 0.00 ( 0.00)%
Icon

Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - Specialty & Generic | NYE
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 7.78

0.00 (0.00)%

USD 3.59B

1.66M

USD 10.00(+28.53%)

USD 6.00 (-22.88%)

Icon

AMRX

Amneal Pharmaceuticals, Inc. Class A Common Stock (USD)
COMMON STOCK | NYE
USD 7.78
0.00 ( 0.00)%
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 3.59B

USD 6.00 (-22.88%)

USD 7.78

Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) Stock Forecast

Show ratings and price targets of :
USD 10.00
(+28.53%)

Based on the Amneal Pharmaceuticals, Inc. Class A Common Stock stock forecast from 4 analysts, the average analyst target price for Amneal Pharmaceuticals, Inc. Class A Common Stock is USD 10.00 over the next 12 months. Amneal Pharmaceuticals, Inc. Class A Common Stock’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Amneal Pharmaceuticals, Inc. Class A Common Stock is Slightly Bearish, which is based on 5 positive signals and 8 negative signals. At the last closing, Amneal Pharmaceuticals, Inc. Class A Common Stock’s stock price was USD 7.78. Amneal Pharmaceuticals, Inc. Class A Common Stock’s stock price has changed by -0.64% over the past week, -7.27% over the past month and +35.07% over the last year.

No recent analyst target price found for Amneal Pharmaceuticals, Inc. Class A Common Stock
No recent average analyst rating found for Amneal Pharmaceuticals, Inc. Class A Common Stock

Company Overview Amneal Pharmaceuticals, Inc. Class A Common Stock

Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide. The company operates through three segments: Generics, Specialty, and AvKARE...Read More

https://amneal.com

400 Crossing Boulevard, Bridgewater, NJ, United States, 08807

7,850

December

USD

USA

Adjusted Closing Price for Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)

Loading...

Unadjusted Closing Price for Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)

Loading...

Share Trading Volume for Amneal Pharmaceuticals, Inc. Class A Common Stock Shares

Loading...

Compare Performance of Amneal Pharmaceuticals, Inc. Class A Common Stock Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for AMRX

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Amneal Pharmaceuticals, Inc. Class A Common Stock (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ZTS
Zoetis Inc 0.00 (0.00%) USD74.37B 30.99 20.99

Frequently Asked Questions About Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) Stock

Based on ratings from 4 analysts Amneal Pharmaceuticals, Inc. Class A Common Stock's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 5 buy, sell and 1 hold ratings.

Unfortunately we do not have enough data on AMRX's stock to indicate if its a good dividend stock.

Based on targets from 4 analysts, the average taret price for AMRX is USD 10.00 over the next 12 months. The maximum analyst target price is USD 12 while the minimum anlayst target price is USD 8.

AMRX stock's Price/Earning ratio is 89.83. Our analysis grades AMRX stock's Price / Earning ratio at F. This means that AMRX stock's Price/Earning ratio is above 78% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NYE exchange. Based on this AMRX may be a overvalued for its sector.

The last closing price of AMRX's stock was USD 7.78.

The most recent market capitalization for AMRX is USD 3.59B.

Based on targets from 4 analysts, the average taret price for AMRX is projected at USD 10.00 over the next 12 months. This means that AMRX's stock price may go up by +28.53% over the next 12 months.

We can't find any ETFs which contains Amneal Pharmaceuticals, Inc. Class A Common Stock's stock.

As per our most recent records Amneal Pharmaceuticals, Inc. Class A Common Stock has 7,850 Employees.

Amneal Pharmaceuticals, Inc. Class A Common Stock's registered address is 400 Crossing Boulevard, Bridgewater, NJ, United States, 08807. You can get more information about it from Amneal Pharmaceuticals, Inc. Class A Common Stock's website at https://amneal.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Frequently Asked Questions About Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) Stock

Based on ratings from 4 analysts Amneal Pharmaceuticals, Inc. Class A Common Stock's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 5 buy, sell and 1 hold ratings.

Unfortunately we do not have enough data on AMRX's stock to indicate if its a good dividend stock.

Based on targets from 4 analysts, the average taret price for AMRX is USD 10.00 over the next 12 months. The maximum analyst target price is USD 12 while the minimum anlayst target price is USD 8.

AMRX stock's Price/Earning ratio is 89.83. Our analysis grades AMRX stock's Price / Earning ratio at F. This means that AMRX stock's Price/Earning ratio is above 78% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NYE exchange. Based on this AMRX may be a overvalued for its sector.

The last closing price of AMRX's stock was USD 7.78.

The most recent market capitalization for AMRX is USD 3.59B.

Based on targets from 4 analysts, the average taret price for AMRX is projected at USD 10.00 over the next 12 months. This means that AMRX's stock price may go up by +28.53% over the next 12 months.

We can't find any ETFs which contains Amneal Pharmaceuticals, Inc. Class A Common Stock's stock.

As per our most recent records Amneal Pharmaceuticals, Inc. Class A Common Stock has 7,850 Employees.

Amneal Pharmaceuticals, Inc. Class A Common Stock's registered address is 400 Crossing Boulevard, Bridgewater, NJ, United States, 08807. You can get more information about it from Amneal Pharmaceuticals, Inc. Class A Common Stock's website at https://amneal.com.
Loading...